Likewise, TGF-β signaling also induces CSCs-driven platinum, paclitaxel, 5-fluorouracil, and docetaxel resistance in breast cancer, gastric cancer, and prostate cancer [16–19]. The gene discussed is TGFB1; the disease is breast carcinoma.